High Doses of Colchicine Act As "Silver Bullets" Against Severe COVID-19

被引:7
|
作者
Lilov, Alexander [1 ]
Palaveev, Kiril [1 ]
Mitev, Vanyo [2 ]
机构
[1] Sofia Dist Hosp, Specialized Hosp Act Treatment Pneumopneumonia Pht, Pulmonol, Sofia, Bulgaria
[2] Med Univ Sofia, Chem & Biochem, Sofia, Bulgaria
关键词
obesity; survival; colchicine; nlrp3; inflammasome; covid-19;
D O I
10.7759/cureus.54441
中图分类号
R5 [内科学];
学科分类号
1002 ; 100201 ;
摘要
A 48-year-old patient with a weight of 120 kg with type 2 diabetes mellitus, hypertension, and gout was hospitalized on the third day of the COVID-19 diagnosis. His general condition is relatively good, oxygen saturation is 89%. Despite starting standard treatment, on the seventh day from the onset of symptoms, the patient deteriorated sharply (oxygen saturation dropped to 74%). The negative development of the disease is interrupted with a loading dose of colchicine of 6 mg. This is a typical case of the life-saving effect of high but safe doses of colchicine in high-risk COVID-19 patients.
引用
收藏
页数:8
相关论文
共 50 条
  • [1] Effect of increasing doses of colchicine on the treatment of 333 COVID-19 inpatients
    Tiholov, Rumen
    Lilov, Aleksander I.
    Georgieva, Gergana
    Palaveev, Kiril R.
    Tashkov, Konstantin
    Mitev, Vanyo
    IMMUNITY INFLAMMATION AND DISEASE, 2024, 12 (05)
  • [2] Effects of long-term prophylaxis with bromhexine hydrochloride and treatment with high colchicine doses of COVID-19
    Marinov, Krasimir
    Mondeshki, Tsanko
    Georgiev, Hristo
    Dimitrova, Violeta S.
    Mitev, Vanyo
    PHARMACIA, 2025, 72
  • [3] Colchicine-The Divine Medicine against COVID-19
    Mitev, Vanyo
    JOURNAL OF PERSONALIZED MEDICINE, 2024, 14 (07):
  • [4] COVID-19 in patients with gout on colchicine
    Eleftherios Pelechas
    Vassiliki Drossou
    Paraskevi V. Voulgari
    Alexandros A. Drosos
    Rheumatology International, 2021, 41 : 1503 - 1507
  • [5] COVID-19 in patients with gout on colchicine
    Pelechas, Eleftherios
    Drossou, Vassiliki
    Voulgari, Paraskevi V.
    Drosos, Alexandros A.
    RHEUMATOLOGY INTERNATIONAL, 2021, 41 (08) : 1503 - 1507
  • [6] Effect of combined use of ivermectin and colchicine in COVID-19 patients
    El Sayed, Rania Gamal
    Hafez, Amr Fouad
    Mohammed Haggag, Adham Magdy Ahmed
    Alhadidy, Mohamed A.
    EGYPTIAN JOURNAL OF ANAESTHESIA, 2022, 38 (01): : 365 - 372
  • [7] High-Dose Colchicine: Key Factor in the Treatment of Morbidly Obese COVID-19 Patients
    Mondeshki, Tsanko
    Mitev, Vanyo
    CUREUS JOURNAL OF MEDICAL SCIENCE, 2024, 16 (04)
  • [8] Colchicine in the management of Covid-19: With or lieu of evidence
    Al-Kuraishy, Hayder Mutter
    Hussien, Nawar Raad
    Al-Niemi, Marwa Salih
    Al-Gareeb, Ali Ismail
    JOURNAL OF THE PAKISTAN MEDICAL ASSOCIATION, 2021, 71 (12) : S127 - S132
  • [9] High versus standard doses of corticosteroids in severe COVID-19: a retrospective cohort study
    Enric Monreal
    Susana Sainz de la Maza
    Elena Natera-Villalba
    Álvaro Beltrán-Corbellini
    Fernando Rodríguez-Jorge
    Jose Ignacio Fernández-Velasco
    Paulette Walo-Delgado
    Alfonso Muriel
    Javier Zamora
    Araceli Alonso-Canovas
    Jesús Fortún
    Luis Manzano
    Beatriz Montero-Errasquín
    Lucienne Costa-Frossard
    Jaime Masjuan
    Luisa María Villar
    European Journal of Clinical Microbiology & Infectious Diseases, 2021, 40 : 761 - 769
  • [10] High versus standard doses of corticosteroids in severe COVID-19: a retrospective cohort study
    Monreal, Enric
    Sainz de la Maza, Susana
    Natera-Villalba, Elena
    Beltran-Corbellini, Alvaro
    Rodriguez-Jorge, Fernando
    Fernandez-Velasco, Jose Ignacio
    Walo-Delgado, Paulette
    Muriel, Alfonso
    Zamora, Javier
    Alonso-Canovas, Araceli
    Fortun, Jesus
    Manzano, Luis
    Montero-Errasquin, Beatriz
    Costa-Frossard, Lucienne
    Masjuan, Jaime
    Villar, Luisa Maria
    EUROPEAN JOURNAL OF CLINICAL MICROBIOLOGY & INFECTIOUS DISEASES, 2021, 40 (04) : 761 - 769